Literature DB >> 15160778

Conforming to HIPAA regulations and compilation of research data.

Steven L Clause1, Darren M Triller, Colleen P H Bornhorst, Robert A Hamilton, Leon E Cosler.   

Abstract

PURPOSE: A set of deidentified patient data compliant with the Health Information Portability and Accountability Act (HIPAA) was compiled, the data lost as a function of unique data elements (UDEs) were measured, and the deidentified data were tested for potential for reidentification.
METHODS: After approval by the institutional review board of an integrated health system, a limited-data set was created by querying the health system's pharmacy, administrative, and financial files for patients discharged between January 1 and December 31, 2000. Using the HIPAA "safe-harbor" method, this limited-data set was converted into a deidentified-data table for future statistical analysis, and UDEs in both data sets were identified and quantified. Unique combinations of commonly available data were also identified.
RESULTS: The limited-data set, representing 4,738 patient discharges, contained 810,456 UDEs in 322,657 records organized into four data tables (demographics, diagnoses, medication orders, and laboratory test results). The deidentified-data table, representing 4,722 discharges, contained 562,171 UDEs in 128 data-type columns in a single data table. About 31% of the data volume was lost. Much of the information lost was of the type that is of special interest to researchers (e.g., time between episodes of care, ages of >89 years).
CONCLUSION: A study suggested that deidentified patient data with a reasonable degree of protection against reidentification were less complete than may be necessary for good research.

Entities:  

Mesh:

Year:  2004        PMID: 15160778     DOI: 10.1093/ajhp/61.10.1025

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  8 in total

1.  Protecting privacy using k-anonymity.

Authors:  Khaled El Emam; Fida Kamal Dankar
Journal:  J Am Med Inform Assoc       Date:  2008-06-25       Impact factor: 4.497

Review 2.  Impact of the Health Insurance Portability and Accountability Act on participant recruitment and retention.

Authors:  Deidre D Wipke-Tevis; Melissa A Pickett
Journal:  West J Nurs Res       Date:  2007-06-05       Impact factor: 1.967

3.  Methods for the de-identification of electronic health records for genomic research.

Authors:  Khaled El Emam
Journal:  Genome Med       Date:  2011-04-27       Impact factor: 11.117

4.  The re-identification risk of Canadians from longitudinal demographics.

Authors:  Khaled El Emam; David Buckeridge; Robyn Tamblyn; Angelica Neisa; Elizabeth Jonker; Aman Verma
Journal:  BMC Med Inform Decis Mak       Date:  2011-06-22       Impact factor: 2.796

5.  Establishing the role of honest broker: bridging the gap between protecting personal health data and clinical research efficiency.

Authors:  Hyo Joung Choi; Min Joung Lee; Chang-Min Choi; JaeHo Lee; Soo-Yong Shin; Yungman Lyu; Yu Rang Park; Soyoung Yoo
Journal:  PeerJ       Date:  2015-12-17       Impact factor: 2.984

6.  HealtheDataLab - a cloud computing solution for data science and advanced analytics in healthcare with application to predicting multi-center pediatric readmissions.

Authors:  Louis Ehwerhemuepha; Gary Gasperino; Nathaniel Bischoff; Sharief Taraman; Anthony Chang; William Feaster
Journal:  BMC Med Inform Decis Mak       Date:  2020-06-19       Impact factor: 2.796

7.  Twenty Years of the Health Insurance Portability and Accountability Act Safe Harbor Provision: Unsolved Challenges and Ways Forward.

Authors:  Brittany Krzyzanowski; Steven M Manson
Journal:  JMIR Med Inform       Date:  2022-08-03

8.  The experience of accommodating privacy restrictions during implementation of a large-scale surveillance study of an osteoporosis medication.

Authors:  Kirk D Midkiff; Elizabeth B Andrews; Alicia W Gilsenan; Dennis M Deapen; David H Harris; Maria J Schymura; Francis J Hornicek
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-04-19       Impact factor: 2.890

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.